• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生长缓慢及停止生长的婴儿血管瘤:0.5%马来酸噻吗洛尔局部用药的临床特征及治疗结果

Infantile Hemangiomas with Minimal and Arrested Growth: Clinical Features and Treatment Outcomes with 0.5% Topical Timolol Maleate.

作者信息

Bae Kyung-Nam, Shin Kihyuk, Kim Hoon-Soo, Kim Byung-Soo, Kim Moon-Bum, Ko Hyun-Chang

机构信息

Department of Dermatology, School of Medicine, Pusan National University, Busan, Korea.

Department of Dermatology, Pusan National University Yangsan Hospital, Busan, Korea.

出版信息

Ann Dermatol. 2021 Oct;33(5):448-455. doi: 10.5021/ad.2021.33.5.448. Epub 2021 Sep 8.

DOI:10.5021/ad.2021.33.5.448
PMID:34616126
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8460486/
Abstract

BACKGROUND

A minority of infantile hemangiomas showing minimal or arrested growth (IH-MAGs) have been recognized in the literature. Nevertheless, the clinical features and treatment outcomes of IH-MAGs have not been well investigated.

OBJECTIVE

This study aimed to understand the clinical characteristics of IH-MAGs better and their response to treatment with topical timolol maleate.

METHODS

We retrospectively reviewed medical records and clinical images of patients with IH-MAGs. Treatment response with topical timolol was assessed in both IH-MAGs and classic infantile hemangiomas (IHs) groups.

RESULTS

Of the 1,038 patients with IHs, only 31 (3.0%) were diagnosed with IH-MAGs. Lesions with non-proliferative components were more frequently distributed in the lower half of the body (61.5%) than those with proliferative components (16.7%). In 14 patients treated with topical timolol, the global assessment scale showed more significant and rapid improvement than in those with classic IHs.

CONCLUSION

Although the prevalence of IH-MAGs may be relatively low, understanding their clinical features will help in differential diagnosis. Furthermore, these type of lesions might be more responsive to topical timolol than classic IHs.

摘要

背景

文献中已认识到少数显示最小或停止生长的婴儿血管瘤(IH-MAGs)。然而,IH-MAGs的临床特征和治疗结果尚未得到充分研究。

目的

本研究旨在更好地了解IH-MAGs的临床特征及其对局部使用马来酸噻吗洛尔治疗的反应。

方法

我们回顾性分析了IH-MAGs患者的病历和临床图像。评估了IH-MAGs组和经典婴儿血管瘤(IHs)组局部使用噻吗洛尔的治疗反应。

结果

在1038例IHs患者中,只有31例(3.0%)被诊断为IH-MAGs。具有非增殖成分的病变在下半身的分布(61.5%)比具有增殖成分的病变(16.7%)更频繁。在14例接受局部使用噻吗洛尔治疗的患者中,整体评估量表显示比经典IHs患者有更显著和快速的改善。

结论

尽管IH-MAGs的患病率可能相对较低,但了解其临床特征将有助于鉴别诊断。此外,这类病变可能比经典IHs对局部使用噻吗洛尔更敏感。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a537/8460486/167b2052677a/ad-33-448-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a537/8460486/f6735588f08f/ad-33-448-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a537/8460486/67d4f095ebe8/ad-33-448-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a537/8460486/a10809b0f637/ad-33-448-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a537/8460486/167b2052677a/ad-33-448-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a537/8460486/f6735588f08f/ad-33-448-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a537/8460486/67d4f095ebe8/ad-33-448-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a537/8460486/a10809b0f637/ad-33-448-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a537/8460486/167b2052677a/ad-33-448-g004.jpg

相似文献

1
Infantile Hemangiomas with Minimal and Arrested Growth: Clinical Features and Treatment Outcomes with 0.5% Topical Timolol Maleate.生长缓慢及停止生长的婴儿血管瘤:0.5%马来酸噻吗洛尔局部用药的临床特征及治疗结果
Ann Dermatol. 2021 Oct;33(5):448-455. doi: 10.5021/ad.2021.33.5.448. Epub 2021 Sep 8.
2
Infantile hemangiomas with minimal or arrested growth: a retrospective case series.生长缓慢或停止生长的婴幼儿血管瘤:一项回顾性病例系列研究
Arch Dermatol. 2010 Sep;146(9):971-6. doi: 10.1001/archdermatol.2010.197.
3
Efficacy and Safety of Topical Timolol for the Treatment of Infantile Hemangioma in the Early Proliferative Stage: A Randomized Clinical Trial.局部用噻吗洛尔治疗婴儿血管瘤早期增殖期的疗效和安全性:一项随机临床试验。
JAMA Dermatol. 2021 May 1;157(5):583-587. doi: 10.1001/jamadermatol.2021.0596.
4
Infantile Hemangiomas with Minimal or Arrested Growth - Do They Occur More Often in Premature Infants Than It Seemed?婴儿血管瘤生长缓慢或停止生长-早产儿中是否比看上去更常见?
Acta Dermatovenerol Croat. 2021 Nov;29(4):196-202.
5
Good Clinical Responders to Topical Timolol in Patients with Infantile Hemangiomas: A 7-Year Retrospective Study of 328 Korean Patients.噻吗洛尔局部用药治疗婴幼儿血管瘤的良好临床反应者:一项对328例韩国患者的7年回顾性研究
Ann Dermatol. 2022 Oct;34(5):360-369. doi: 10.5021/ad.21.203.
6
Topical Application of 0.5% Timolol Maleate Hydrogel for the Treatment of Superficial Infantile Hemangiomas.马来酸噻吗洛尔 0.5%水凝胶局部治疗表浅婴幼儿血管瘤。
J Drugs Dermatol. 2023 Jun 1;22(6):594-598. doi: 10.36849/JDD.7054.
7
Infantile hemangiomas with minimal or arrested growth associated with soft tissue hypertrophy: a case series of 10 patients.伴有软组织肥大的生长缓慢或消退型婴儿血管瘤:10 例病例系列。
J Eur Acad Dermatol Venereol. 2017 Nov;31(11):1924-1929. doi: 10.1111/jdv.14457. Epub 2017 Aug 13.
8
Topical Application of 0.5% Timolol Maleate Hydrogel for the Treatment of Superficial Infantile Hemangioma.0.5% 马来酸噻吗洛尔水凝胶局部应用治疗浅表性婴幼儿血管瘤
Front Oncol. 2017 Jun 27;7:137. doi: 10.3389/fonc.2017.00137. eCollection 2017.
9
Topical Timolol Maleate 0.5% for Infantile Hemangioma: Its Effectiveness Compared to Ultrapotent Topical Corticosteroids - A Single-Center Experience of 278 Cases.0.5%马来酸噻吗洛尔局部用药治疗婴幼儿血管瘤:与超强效局部用皮质类固醇激素相比的疗效——278例单中心经验
Dermatology. 2016;232(5):566-571. doi: 10.1159/000448396. Epub 2016 Sep 3.
10
Timolol maleate 0.5% or 0.1% gel-forming solution for infantile hemangiomas: a retrospective, multicenter, cohort study.用于婴儿血管瘤的0.5%或0.1%马来酸噻吗洛尔凝胶形成溶液:一项回顾性、多中心队列研究。
Pediatr Dermatol. 2012 Jan-Feb;29(1):28-31. doi: 10.1111/j.1525-1470.2011.01664.x. Epub 2011 Dec 9.

引用本文的文献

1
Application of color Doppler ultrasound in the treatment of infantile hemangioma by applying timolol combined with Cynergy dual-wavelength laser : Application of color Doppler ultrasound in the treatment of infantile hemangioma.彩色多普勒超声在噻吗洛尔联合Cynergy双波长激光治疗婴幼儿血管瘤中的应用:彩色多普勒超声在婴幼儿血管瘤治疗中的应用。
Lasers Med Sci. 2025 Feb 18;40(1):101. doi: 10.1007/s10103-025-04356-4.
2
Infantile Hemangioma with Minimal or Arrested Growth (IHMAG): A Retrospective Analysis of Clinical and Dermoscopic Diagnostic Clues.生长极小或停止生长的婴儿血管瘤(IHMAG):临床和皮肤镜诊断线索的回顾性分析
Dermatol Pract Concept. 2024 Jul 1;14(3):e2024206. doi: 10.5826/dpc.1403a206.

本文引用的文献

1
Infantile hemangiomas with minimal or arrested growth: A retrospective case series.生长缓慢或停止生长的婴儿血管瘤:一项回顾性病例系列研究。
Pediatr Dermatol. 2019 Jan;36(1):125-131. doi: 10.1111/pde.13695. Epub 2018 Oct 15.
2
Eczematous dermatitis in an infantile hemangioma with minimal or arrested growth.生长 minimal 或停滞的婴儿血管瘤中的湿疹性皮炎 。(原英文中“minimal”含义不完整,推测可能是“minimal growth”即“最小生长”或“微小生长”,但按字面准确翻译是上述译文)
Pediatr Dermatol. 2018 Mar;35(2):261-262. doi: 10.1111/pde.13368. Epub 2017 Dec 20.
3
Infantile hemangiomas with minimal or arrested growth associated with soft tissue hypertrophy: a case series of 10 patients.
伴有软组织肥大的生长缓慢或消退型婴儿血管瘤:10 例病例系列。
J Eur Acad Dermatol Venereol. 2017 Nov;31(11):1924-1929. doi: 10.1111/jdv.14457. Epub 2017 Aug 13.
4
Infantile Hemangioma with Minimal or Arrested Growth: Further Observations on Clinical and Histopathologic Findings of this Unique but Underrecognized Entity.生长缓慢或停止生长的婴儿血管瘤:对这一独特但未被充分认识的实体的临床和组织病理学发现的进一步观察
Pediatr Dermatol. 2017 Jan;34(1):64-71. doi: 10.1111/pde.13022. Epub 2016 Nov 22.
5
Expression of β-Adrenergic Receptor Subtypes in Proliferative, Involuted, and Propranolol-Responsive Infantile Hemangiomas.β-肾上腺素能受体亚型在增殖期、消退期及对普萘洛尔有反应的婴儿血管瘤中的表达
JAMA Facial Plast Surg. 2017 Mar 1;19(2):102-107. doi: 10.1001/jamafacial.2016.1188.
6
Hemangioma Activity and Severity Index (HASI), an instrument for evaluating infantile hemangioma: development and preliminary validation.血管瘤活动度和严重程度指数(HASI):一种评估婴幼儿血管瘤的工具——开发与初步验证
Int J Dermatol. 2015 Apr;54(4):494-8. doi: 10.1111/ijd.12646. Epub 2014 Dec 29.
7
Topical timolol maleate 0.5% for infantile hemangioma; it's effectiveness and/or adjunctive pulsed dye laser - single center experience of 102 cases in Korea.0.5%马来酸噻吗洛尔外用治疗婴幼儿血管瘤;其有效性及/或联合脉冲染料激光——韩国102例单中心经验
J Dermatolog Treat. 2015;26(4):389-91. doi: 10.3109/09546634.2014.990412. Epub 2014 Dec 29.
8
β-Adrenergic receptor expression in vascular tumors.血管肿瘤中的β-肾上腺素能受体表达。
Mod Pathol. 2012 Nov;25(11):1446-51. doi: 10.1038/modpathol.2012.108. Epub 2012 Jun 29.
9
Topical timolol maleate for treatment of infantile haemangiomas: preliminary results of a prospective study.马来酸噻吗洛尔滴眼液治疗婴幼儿血管瘤:前瞻性研究的初步结果。
Clin Exp Dermatol. 2013 Mar;38(2):143-6. doi: 10.1111/j.1365-2230.2012.04425.x. Epub 2012 Jun 25.
10
Measuring the severity of infantile hemangiomas: instrument development and reliability.测量婴儿血管瘤的严重程度:工具开发与可靠性
Arch Dermatol. 2012 Feb;148(2):197-202. doi: 10.1001/archdermatol.2011.926.